• 1
    Marcus R, Holloway L, Wells B, Greendale G, James MK, Wasilauskas C, Kelaghan J 1999 The relationship of biochemical markers of bone turnover to bone density changes in postmenopausal women: Results from the Postmenopausal Estrogen/Progestin Interventions (PEPI) trial. J Bone Miner Res 14:15831595.
  • 2
    Melton LJ III, Khosla S, Atkinson EJ, O'Fallon WM, Riggs BL 1997 Relationship of bone turnover to bone density and fractures. J Bone Miner Res 12:10831091.
  • 3
    Riis BJ, Hansen MA, Jensen AM, Overgaard K, Christiansen C 1996 Low bone mass and fast rate of bone loss at menopause. Equal risk factors for future fracture: A 15-year follow-up study. Bone 19:912.
  • 4
    de Vernejoul MC 1998 Markers of bone remodelling in metabolic bone disease. Drugs Aging 12(Suppl 1):914.
  • 5
    Kanis JA 2002 Diagnosis of osteoporosis and assessment of fracture risk. Lancet 359:19291936.
  • 6
    Akesson K, Ljunghall S, Jonsson B, Sernbo I, Johnell O, Gardsell P, Obrant KJ 1995 Assessment of biochemical markers of bone metabolism in relation to the occurrence of fracture: A retrospective and prospective population-based study of women. J Bone Miner Res 10:18231829.
  • 7
    van Daele PL, Seibel MJ, Burger H, Hofman A, Grobbee DE, van Leeuwen JP, Birkenhager JC, Pols HA 1996 Case-control analysis of bone resorption markers, disability, and hip fracture risk: The Rotterdam study. BMJ 312:482483.
  • 8
    Garnero P, Hausherr E, Chapuy MC, Marcelli C, Grandjean H, Muller C, Cormier C, Breart G, Meunier PJ, Delmas PD 1996 Markers of bone resorption predict hip fracture in elderly women: The EPIDOS Prospective Study. J Bone Miner Res 11:15311538.
  • 9
    Garnero P, Sornay-Rendu E, Claustrat B, Delmas PD 2000 Biochemical markers of bone turnover, endogenous hormones and the risk of fractures in postmenopausal women: The OFELY study. J Bone Miner Res 15:15261536.
  • 10
    Garnero P, Cloos P, Sornay-Rendu E, Qvist P, Delmas PD 2002 Type I collagen racemization and isomerization and the risk of fracture in postmenopausal women: The OFELY prospective study. J Bone Miner Res 17:826833.
  • 11
    Luukinen H, Kakonen SM, Pettersson K, Koski K, Laippala P, Lovgren T, Kivela SL, Vaananen HK 2000 Strong prediction of fractures among older adults by the ratio of carboxylated to total serum osteocalcin. J Bone Miner Res 15:24732478.
  • 12
    Chapurlat RD, Garnero P, Breart G, Meunier PJ, Delmas PD 2000 Serum type I collagen breakdown product (serum CTX) predicts hip fracture risk in elderly women: The EPIDOS study. Bone 27:283286.
  • 13
    Bruyere O, Collette J, Delmas P, Rouillon A, Roux C, Seidel L, Richy F, Reginster JY 2003 Interest of biochemical markers of bone turnover for long-term prediction of new vertebral fracture in postmenopausal osteoporotic women. Maturitas 44:259265.
  • 14
    Ross PD, Kress BC, Parson RE, Wasnich RD, Armour KA, Mizrahi IA 2000 Serum bone alkaline phosphatase and calcaneus bone density predict fractures: A prospective study. Osteoporos Int 11:7682.
  • 15
    Riggs BL, Melton LJ III 1983 Evidence for two distinct syndromes of involutional osteoporosis. Am J Med 75:899901.
  • 16
    Garnero P 2000 Markers of bone turnover for the prediction of fracture risk. Osteoporos Int 11(Suppl 6):S55S65.
  • 17
    Halleen JM, Alatalo SL, Suominen H, Cheng S, Janckila AJ, Vaananen HK 2000 Tartrate-resistant acid phosphatase 5b: A novel serum marker of bone resorption. J Bone Miner Res 15:13371345.
  • 18
    Ivaska KK, Hellman J, Likojarvi J, Kakonen SM, Gerdhem P, Akesson K, Obrant KJ, Pettersson K, Vaananen HK 2003 Identification of novel proteolytic forms of osteocalcin in human urine. Biochem Biophys Res Commun 306:973980.
  • 19
    Delmas PD, Eastell R, Garnero P, Seibel MJ, Stepan J 2000 The use of biochemical markers of bone turnover in osteoporosis. Committee of Scientific Advisors of the International Osteoporosis Foundation. Osteoporos Int 11(Suppl 6):S2S17.
  • 20
    Kakonen SM, Hellman J, Karp M, Laaksonen P, Obrant KJ, Vaananen HK, Lovgren T, Pettersson K 2000 Development and evaluation of three immunofluorometric assays that measure different forms of osteocalcin in serum. Clin Chem 46:332337.
  • 21
    Karlsson MK, Obrant KJ, Nilsson BE, Johnell O 1998 Bone mineral density assessed by quantitative ultrasound and dual energy X-ray absorptiometry. Normative data in Malmo, Sweden. Acta Orthop Scand 69:189193.
  • 22
    Vergnaud P, Garnero P, Meunier PJ, Breart G, Kamihagi K, Delmas PD 1997 Undercarboxylated osteocalcin measured with a specific immunoassay predicts hip fracture in elderly women: The EPIDOS Study. J Clin Endocrinol Metab 82:719724.
  • 23
    Rosenquist C, Qvist P, Bjarnason N, Christiansen C 1995 Measurement of a more stable region of osteocalcin in serum by ELISA with two monoclonal antibodies. Clin Chem 41:14391445.
  • 24
    Plantalech L, Guillaumont M, Vergnaud P, Leclercq M, Delmas PD 1991 Impairment of gamma carboxylation of circulating osteocalcin (bone gla protein) in elderly women. J Bone Miner Res 6:12111216.
  • 25
    Johnell O, Oden A, De Laet C, Garnero P, Delmas PD, Kanis JA 2002 Biochemical indices of bone turnover and the assessment of fracture probability. Osteoporos Int 13:523526.
  • 26
    Halleen JM, Alatalo SL, Janckila AJ, Woitge HW, Seibel MJ, Vaananen HK 2001 Serum tartrate-resistant acid phosphatase 5b is a specific and sensitive marker of bone resorption. Clin Chem 47:597600.
  • 27
    Janckila AJ, Takahashi K, Sun SZ, Yam LT 2001 Tartrate-resistant acid phosphatase isoform 5b as serum marker for osteoclastic activity. Clin Chem 47:7480.
  • 28
    Halleen JM, Ylipahkala H, Alatalo SL, Janckila AJ, Heikkinen JE, Suominen H, Cheng S, Vaananen HK 2002 Serum tartrate-resistant acid phosphatase 5b, but not 5a, correlates with other markers of bone turnover and bone mineral density. Calcif Tissue Int 71:2025.
  • 29
    Akesson K, Kakonen SM, Karlsson MK, Lovgren T, Pettersson K, Obrant KJ 1999 Fracture induces long-term effects on bone turnover in humans. J Bone Miner Res 14:S1;S272.
  • 30
    Srivastava AK, Mohan S, Singer FR, Baylink DJ 2002 A urine midmolecule osteocalcin assay shows higher discriminatory power than a serum midmolecule osteocalcin assay during short-term alendronate treatment of osteoporotic patients. Bone 31:6269.
  • 31
    Ju HS, Leung S, Brown B, Stringer MA, Leigh S, Scherrer C, Shepard K, Jenkins D, Knudsen J, Cannon R 1997 Comparison of analytical performance and biological variability of three bone resorption assays. Clin Chem 43:15701576.
  • 32
    Schlemmer A, Hassager C 1999 Acute fasting diminishes the circadian rhythm of biochemical markers of bone resorption. Eur J Endocrinol 140:332337.
  • 33
    Greenspan SL, Dresner-Pollak R, Parker RA, London D, Ferguson L 1997 Diurnal variation of bone mineral turnover in elderly men and women. Calcif Tissue Int 60:419423.
  • 34
    Clowes JA, Hannon RA, Yap TS, Hoyle NR, Blumsohn A, Eastell R 2002 Effect of feeding on bone turnover markers and its impact on biological variability of measurements. Bone 30:886890.
  • 35
    Bjarnason NH, Henriksen EE, Alexandersen P, Christgau S, Henriksen DB, Christiansen C 2002 Mechanism of circadian variation in bone resorption. Bone 30:307313.
  • 36
    Sernbo I, Johnell O 1993 Consequences of a hip fracture: A prospective study over 1 year. Osteoporos Int 3:148153.
  • 37
    Hasserius R 2003 Vertebral deformity and vertebral fracture in the elderly. Thesis, Lund University, Lund, Sweden.